Company Filing History:
1 out of 8 
1 out of 159 
1 out of 100 Years Active: 2020
Title: The Innovative Journey of Inventor Dong Ma
Introduction
Dong Ma is a notable inventor based in Shanghai, China, recognized for his significant contributions to the field of biopharmaceuticals. With one patent to his name, he has made strides in the development of cancer treatment therapies. His work exemplifies the intersection of innovation and healthcare, aiming to improve the efficacy of oncological treatments.
Latest Patents
Dong Ma holds a patent for an "Anti-c-Met antibody and anti-c-Met antibody-cytotoxic drug conjugate and pharmaceutical use thereof." This patent includes the development of a chimeric antibody or a humanized antibody, along with pharmaceutical compositions that incorporate the humanized anti-c-Met antibody. The formulations aim to enhance treatment options for cancer patients and represent a significant advancement in targeted therapy.
Career Highlights
Throughout his career, Dong Ma has been associated with notable companies in the biopharmaceutical sector. He has worked at Suzhou Suncadia Biopharmaceuticals Co., Ltd. and Jiangsu Hengrui Medicine Company Ltd., where he contributed his expertise in antibody development and drug conjugation. His work has not only advanced his own career but also significantly impacted the organizations he has been part of.
Collaborations
During his professional journey, Dong Ma collaborated with esteemed individuals like Jiajian Liu and Lianshan Zhang. These partnerships have fostered a collaborative environment that encourages innovative solutions in the biopharmaceutical industry, enhancing the overall efficacy of their research efforts.
Conclusion
Dong Ma stands out as an innovative force in the field of cancer treatment through his focus on antibody and drug conjugate technologies. His patent reflects a commitment to improving healthcare outcomes and showcases his potential for further contributions in the biopharmaceutical landscape. As research continues to evolve, Dong Ma's work will undoubtedly play a crucial role in addressing the challenges posed by cancer therapeutics.